These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. Gutermuth J, Audring H, Voit C, Trefzer U, Haas N. J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):477-9. PubMed ID: 15196167 [Abstract] [Full Text] [Related]
29. Benign eccrine poroma of the dorsum of the hand: predilection for the nail fold and P53 positivity. Al-Qattan MM, Al-Turaiki TM, Al-Oudah N, Arab K. J Hand Surg Eur Vol; 2009 Jun; 34(3):402-3. PubMed ID: 19457912 [No Abstract] [Full Text] [Related]
38. Clear-cell porocarcinoma in situ: a cytologic variant of porocarcinoma in situ. Rutten A, Requena L, Requena C. Am J Dermatopathol; 2002 Feb; 24(1):67-71. PubMed ID: 11803286 [Abstract] [Full Text] [Related]
39. Cytologic findings in a case of malignant eccrine poroma. López JI, Rodil MA, Ballestín C. Acta Cytol; 1996 Feb; 40(2):386-7. PubMed ID: 8629435 [No Abstract] [Full Text] [Related]